Harm Reduction Therapeutics
  • About
  • Naloxone
  • Resources
  • News
  • Contact
Select Page

Drug companies could have made naloxone more accessible. Why didn’t they?

https://www.washingtonpost.com/opinions/2023/01/23/naloxone-over-the-counter-opioid-overdose-antidote/#new_tab
FDA Fast-Tracks Review of Overdose Drug Naloxone for Use Without Prescription

FDA Fast-Tracks Review of Overdose Drug Naloxone for Use Without Prescription

by Philip Kantor | Jan 3, 2023 | News

   
New Drug Application for RiVive™ Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA

New Drug Application for RiVive™ Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA

by Philip Kantor | Jan 3, 2023 | News

About

Harm Reduction Therapeutics (HRT), Inc. is a 501(c)(3) non-profit pharmaceutical company whose mission is to prevent opioid overdose deaths by making free or low-cost over-the-counter naloxone available to everyone. Founded in 2017 in response to the severe price and access limits to existing naloxone products, HRT brings together experts in drug development, harm reduction, substance dependence, public health policy, and over-the-counter switches of prescription pharmaceuticals.

Social

  • Twitter
  • Instagram

Useful Links

  • Home
  • About
  • Naloxone
  • Resources
  • News
  • Contact
© Copyright 2022 Harm Reduction Therapeutics. All Rights Reserved. Privacy. Accessibility.